Literature DB >> 24111905

Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study.

Alessia Pepe1, Antonella Meloni, Giuseppe Rossi, Vincenzo Caruso, Liana Cuccia, Anna Spasiano, Calogera Gerardi, Angelo Zuccarelli, Domenico G D'Ascola, Salvatore Grimaldi, Michele Santodirocco, Saveria Campisi, Maria E Lai, Basilia Piraino, Elisabetta Chiodi, Claudio Ascioti, Letizia Gulino, Vincenzo Positano, Massimo Lombardi, Maria R Gamberini.   

Abstract

The relationship between diabetes mellitus (DM) and cardiac complications has never been systematically studied in thalassaemia major (TM). We evaluated a large retrospective historical cohort of TM to determine whether DM is associated with a higher risk of heart complications. We compared 86 TM patients affected by DM with 709 TM patients without DM consecutively included in the Myocardial Iron Overload in Thalassaemia database where clinical/instrumental data are recorded from birth to the first cardiovascular magnetic resonance (CMR) exam. All of the cardiac events considered were developed after the DM diagnosis. In DM patients versus non-DM patients we found a significantly higher frequency of cardiac complications (46.5% vs. 16.9%, P < 0.0001), heart failure (HF) (30.2% vs. 11.7%, P < 0.0001), hyperkinetic arrhythmias (18.6% vs. 5.5%, P < 0.0001) and myocardial fibrosis assessed by late gadolinium enhancement (29.9% vs. 18.4%, P = 0.008). TM patients with DM had a significantly higher risk of cardiac complications [odds ratio (OR) 2.84, P < 0.0001], HF (OR 2.32, P = 0.003), hyperkinetic arrhythmias (OR 2.21, P = 0.023) and myocardial fibrosis (OR 1.91, P = 0.021), also adjusting for the absence of myocardial iron overload assessed by T2* CMR and for the covariates (age and/or endocrine co-morbidity). In conclusion, DM significantly increases the risk for cardiac complications, HF, hyperkinetic arrhythmias and myocardial fibrosis in TM patients.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiac complications; cardiovascular magnetic resonance; diabetes mellitus; myocardial iron overload; thalassaemia major

Mesh:

Year:  2013        PMID: 24111905     DOI: 10.1111/bjh.12557

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  19 in total

1.  Cost-Utility Analysis of Three Iron Chelators Used in Monotherapy for the Treatment of Chronic Iron Overload in β-Thalassaemia Major Patients: An Italian Perspective.

Authors:  Alessia Pepe; Giuseppe Rossi; Anthony Bentley; Maria Caterina Putti; Ludovica Frizziero; Domenico Giuseppe D'Ascola; Liana Cuccia; Anna Spasiano; Aldo Filosa; Vincenzo Caruso; Aishah Hanif; Antonella Meloni
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

2.  Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network.

Authors:  Alessia Pepe; Michele Rizzo; Sara Galimberti; Claudia Baratè; Esther Natalie Oliva; Francesco Arcioni; Sergio Storti; Stefania Renne; Massimo Midiri; Gennaro Restaino; Vincenzo Positano; Maurizio Mangione; Antonella Meloni
Journal:  Ann Hematol       Date:  2021-03-19       Impact factor: 3.673

3.  Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran.

Authors:  Ali Bazi; Javad Sharifi-Rad; Daryoush Rostami; Omolbanin Sargazi-Aval; Amin Safa
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  Evaluation of electrocardiography, echocardiography and cardiac T2* for cardiac complications in beta thalassemia major.

Authors:  Fadime Ersoy Dursun; Gönül Açıksarı; Serçin Özkök; Onur İncealtın
Journal:  Int J Cardiovasc Imaging       Date:  2021-10-08       Impact factor: 2.357

5.  Quantification of pancreatic iron overload and fat infiltration and their correlation with glucose disturbance in pediatric thalassemia major patients.

Authors:  Jingwen Huang; Jun Shen; Qihua Yang; Ziliang Cheng; Xiaodong Chen; Taihui Yu; Jinglian Zhong; Yun Su; Hua Guo; Biling Liang
Journal:  Quant Imaging Med Surg       Date:  2021-02

6.  Effects of blood transfusion on exercise capacity in thalassemia major patients.

Authors:  Daniela Benedetto; Carmelo Massimo Rao; Claudia Cefalù; Demetrio Oreste Aguglia; Gaia Cattadori; Domenico Giuseppe D'Ascola; Frank Antonio Benedetto; Piergiuseppe Agostoni; Susanna Sciomer
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 7.  Mechanisms linking red blood cell disorders and cardiovascular diseases.

Authors:  Ioana Mozos
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

8.  Acute cardiac decompensation in a patient with beta-thalassemia and diabetes mellitus following cessation of chelation therapy.

Authors:  Eirini Lioudaki; Martin Whyte
Journal:  Clin Case Rep       Date:  2016-09-12

9.  The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Saif Al Yaarubi; Nicos Skordis; Doaa Khater; Mohamed El Kholy; Iva Stoeva; Bernadette Fiscina; Michael Angastiniotis; Shahina Daar; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-28       Impact factor: 2.576

10.  Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications.

Authors:  Antonella Meloni; Nicola Martini; Vincenzo Positano; Antonio De Luca; Laura Pistoia; Sara Sbragi; Anna Spasiano; Tommaso Casini; Pier Paolo Bitti; Massimo Allò; Paola Maria Grazia Sanna; Raffaele De Caterina; Gianfranco Sinagra; Alessia Pepe
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-14       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.